Walt Johnston serves as Senior Vice President of Commercial of the Company. As SVP of Commercial, Mr. Johnston will be responsible for marketing, sales and commercial operations. Prior to Urovant, he spent 12 years at Astellas Pharma, most recently as Senior Vice President, Urology and Hospital Business Unit. He led marketing and sales in areas including urology, infectious diseases, and pharmacologic stress agents, and consistently drove double-digit growth in net sales and operating income. Prior to that role, Mr. Johnston was VP of Marketing and New Product Planning. Before Astellas, he spent over 18 years at Pfizer in various roles, including leading the cardiovascular marketing portfolio and as National Sales Director, Vista Rx team. He has a Bachelor of Arts degree from Lafayette College and an MBA from Boston College Carroll School of Management.
Walt's mailing address filed with the SEC is C/O UROVANT SCIENCES, INC., 5281 CALIFORNIA AVE., SUITE 100, IRVINE, CA, 92617.
Over the last 6 years, insiders at Urovant Sciences Ltd have traded over 0$ worth of Urovant Sciences Ltd stock and bought 22,782,569 units worth 411,146,115$ . The most active insiders traders include Sciences Ltd. Roivant、Global Investors Lp Viking ...、Andrew Lo. On average, Urovant Sciences Ltd executives and independent directors trade stock every 6 days with the average trade being worth of 6,293,420$. The most recent stock trade was executed by Chemical Co., Ltd.Sumitomo ... on 19 February 2020, trading 103,250 units of UROV stock currently worth 1,350,510$.
Urovant Sciences Ltd executives and other stock owners filed with the SEC include: